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Role of Flippases in Protein Glycosylation in the 
Endoplasmic Reticulum
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ABSTR ACT: Glycosylation is essential to the synthesis, folding, and function of glycoproteins in eukaryotes. Proteins are co- and posttranslationally 
modified by a variety of glycans in the endoplasmic reticulum (ER); modifications include C- and O-mannosylation, N-glycosylation, and the addition of 
glycosylphosphatidylinositol membrane anchors. Protein glycosylation in the ER of eukaryotes involves enzymatic steps on both the cytosolic and lumenal 
surfaces of the ER membrane. The glycans are first assembled as precursor glycolipids, on the cytosolic surface of the ER, which are tethered to the mem-
brane by attachment to a long-chain polyisoprenyl phosphate (dolichol) containing a reduced α-isoprene. The lipid-anchored building blocks then migrate 
transversely (flip) across the ER membrane to the lumenal surface, where final assembly of the glycan is completed. This strategy allows the cell to export 
high-energy biosynthetic intermediates as lipid-bound glycans, while constraining the glycosyl donors to the site of assembly on the membrane surface. This 
review focuses on the flippases that participate in protein glycosylation in the ER.
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Introduction
Eukaryotic cells are subdivided into organelles by lipid 
bilayers, with a variety of unique functions and lipid com-
positions.1 In addition, the lipid components in the plasma 
membrane are distributed asymmetrically between the two 
monolayers with the aminophospholipids, phosphatidylserine 
and phosphatidylethanolamine, located on the cytoplasmic 
leaflet, and the choline-containing lipids, sphingomyelin and 
phosphatidylcholine, in the exoplasmic leaflet. As the cyto-
plasmic surface of the endoplasmic reticulum (ER) is the site 
of synthesis of the majority of eukaryotic phospholipids, at 
least 50% of the newly synthesized phospholipids must flip 
to the lumenal monolayer to support the uniform expansion 
of the membrane bilayer. The observed final asymmetric dis-
tribution of phospholipids in the plasma membrane is the net 
result of competing bidirectional, energy-independent flip/
floppases and ATP-requiring, phospholipid pumps catalyzing 
the unidirectional transport of phospholipids across the mem-
brane bilayers. Current models suggest that energy-indepen-
dent flip/floppases mediate the transmembrane movement of 
phospholipids in biogenic (self-assembling) membranes, such 
as the ER, and the P-type and ATP-binding cassette trans-
porters function to maintain the transbilayer phospholipid 
asymmetry in membranes, such as the plasma membrane.2–5 
The glycosyl donors employed in protein N-glycosylation, 
C- and O-mannosylation, and glycosylphosphatidylinositol 
membrane (GPI) anchoring are assembled on both sides of the 
ER membrane and require the participation of the bidirec-
tional, energy-independent class of flippase proteins to enter 
the lumen of the ER and participate as glycosyl donors.5–7 
While more properly functioning as scramblases, these trans-
porters will be referred to as flippases, but they should not be 
confused with the phospholipid flip- and floppases.
Protein N-glycosylation requires the synthesis of a pre-
cursor oligosaccharide, containing three glucose (Glc), nine 
mannose (Man), and two N-acetyl glucosamine (GlcNAc) res-
idues, attached to a long-chain polyisoprenyl alcohol (dolichol, 
Dol) via a diphosphate bridge (Glc3Man9GlcNAc2-P-P-Dol, 
G3-DLO [dolichol-linked oligosaccharide]), as illustrated in 
Figure 1.6,8 G3-DLO synthesis is initiated (Step 1, Fig. 1) on 
the cytoplasmic leaflet of the ER with the synthesis of a doli-
chol–diphosphate-linked oligosaccharide intermediate, Man-
5GlcNAc2-P-P-Dol (M5-DLO),9 formed by the sequential 
addition of sugars to dolichyl phosphate (Dol-P) using UDP-
GlcNAc (catalyzed by a complex of DPAGT1 and ALG13/14 
[asparagine-linked glycosylation])10 and GDP-Man (catalyzed 
by a second complex composed of ALG1, ALG2, and 
ALG11)11 as glycosyl donors (Step 1, Fig. 1). The M5-DLO 
intermediate then migrates (flips) from the cytosolic leaflet of 
the ER to the lumenal monolayer (Flippase I, Fig. 1), where 
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four more Man residues are added using mannosyl phosphor-
yldolichol (Man-P-Dol) as mannosyl donor and three Glc 
residues are added using glucosyl phosphoryldolichol (Glc-
P-Dol) as glucosyl donor to form the full-length G3-DLO. 
Man-P-Dol and Glc-P-Dol are also synthesized on the cyto-
solic face of the ER membrane, catalyzed by DPM1/2/3 (Step 
2, Fig. 1) and ALG5 (Step  3, Fig. 1), respectively. Follow-
ing synthesis on the cytosolic monolayer, the dolichol-linked 
intermediates are flipped to the lumenal monolayer by Flip-
pase 2 and Flippase 3 (Fig. 1), where they function as glycosyl 
donors in this pathway. Following en bloc transfer of the pre-
cursor oligosaccharide to protein nascent chains, the carrier 
lipid, Dol-P-P, is discharged on the lumenal leaflet. Dol-P-P 
is dephosphorylated by Dol-P-P phosphatase (DolPP1),12,13 to 
form Dol-P, which is then flipped back to the cytosolic mono-
layer by Flippase 4 (Step 4, Fig. 1), to be reutilized for further 
rounds of DLO synthesis.14
Man-P-Dol also provides the mannosyl units for pro-
tein C- and O-mannosylation and GPI anchor biosynthesis, 
as illustrated in Figure 2.15 Similar to DLO assembly, this 
Man-P-Dol is synthesized on the cytosolic surface of the ER 
membrane and must be transported to the lumenal mono-
layer to function as mannosyl donor. Presumably, the Dol-P 
molecules released by the mannosyltransferase reactions 
are returned to the cytosolic surface for reutilization by the 
same mechanism as the Dol-P formed from Dol-P-P and the 
Man-P-Dol and Glc-P-Dol mediated reactions in G3-DLO 
synthesis on the lumenal leaflet.6
There is substantial evidence supporting the hypoth-
esis that the transbilayer diffusion of the dolichol-linked 
intermediates is facilitated by specialized membrane transport-
ers, termed “flippases”. The highly hydrophobic nature of the 
inner core of the lipid bilayer presents a substantial biophysi-
cal barrier to the spontaneous passage of the hydrophilic head 
Figure 1. Topological model for DLO synthesis in the ER. M5-DLO (Step 1), Man-P-Dol (Step 2), and Glc-P-Dol (Step 3) are synthesized on the 
cytosolic surface of the ER membrane from appropriate sugar-nucleotide donors and Dol-P and diffuse transversely to the lumenal monolayer where 
they participate in the synthesis of full-length G3-DLO. The polar head groups of the dolichol-linked intermediates do not spontaneously cross the 
ER membrane but are escorted across the highly hydrophobic lipid bilayer by a specialized class of membrane transporters referred to as flippases, 
numbered arbitrarily as indicated (Flippase 1: M5-DLO Flippase; Flippase 2: Man-P-Dol Flippase; Flippase 3: Glc-P-Dol Flippase; and Flippase 4: Dol-P 
Flippase). The G3 oligosaccharide is transferred to protein nascent chains releasing a molecule of Dol-P-P, which is dephosphorylated by DolPP1; Dol-P 
is then returned to the cytosolic monolayer by Flippase 4 (Step 4) for utilization in further rounds of DLO synthesis.
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group of the amphipathic dolichol-linked intermediates.5,16–18 
Although all of the glycosyltransferases required to assemble 
the DLO intermediates have been described, the identities 
of the proteins that catalyze the transmembrane movements 
of  the dolichol-linked intermediates and the precise roles of 
two proteins involved in DLO assembly (Lec35 and RFT1) 
have not yet been clearly defined.
The description of this enigmatic class of membrane 
transporters remains a high priority. It is likely that cur-
rently undiagnosed congenital disorders of glycosylation 
(CDG)19–24 will be traced to defects in flippases in the protein 
glycosylation pathways. CDG is a rapidly expanding family 
of genetic diseases attributed to the defective synthesis of gly-
coproteins and glycolipids, and there are presently over 100 
genetic diseases resulting from mutations in glycosylation-
related genes.23 CDG patients present with a wide range of 
clinical symptoms varying from relatively mild, with primar-
ily gastrointestinal effects, to very severe, involving multi-
organ dysfunctions, skeletal abnormalities, and mental and 
psychomotor delay, which often result in embryonic lethality 
or infant mortality.21 As many of these disorders are extremely 
rare, it is not presently known if the range of clinical symptoms 
can be considered diagnostic of a specific disorder or are due 
to the leakiness of the defect.20 It is speculative to attempt to 
predict the clinical features anticipated from specific flippase 
defects; however, some general expectations can be pro-
posed. CDGs arising from defects in Man-P-Dol synthesis 
and utilization (DPM1, 2, and 3-CDG and MPDU1-CDG) 
appear to be quite severe due to the additive effects on protein 
O-mannosylation (α-dystroglycanopathies), GPI anchoring, 
and DLO assembly, which would imply that a Man-P-Dol 
flippase deficiency would have severe consequences. On the 
other hand, defects in Glc-P-Dol utilization (ALG6-CDG 
and ALG8-CDG), are much less severe, suggesting that a 
defect in Glc-P-Dol flippase might be less severe than the 
Man-P-Dol flippase deficiency. M5-DLO flippase deficiency 
might be expected to be similar to CDGs involving the early 
stages in DLO synthesis (DPAGT1-CDG, ALG13/14-
CDG, ALG1-CDG, ALG2-CDG, and ALG11-CDG), 
which are typically severe. The consequences of the prospec-
tive Dol-P recycling flippase are somewhat harder to predict. 
Dol-P flippase deficiency may be similar in scope to those 
Figure 2. Man-P-Dol acts as mannosyl donor for the synthesis of M9-DLO, GPI anchors, and C- and O-mannosylated proteins. Man-P-Dol is 
synthesized on the cytosolic monolayer of the ER membrane from GDP-Man and Dol-P and flips (Flippase 2) to the lumenal monolayer where it 
functions as mannosyl donor for four mannosyltransferases in the DLO pathway and three mannosyltransferases in GPI anchor assembly. At least 
seven O-mannosyltransferases have been characterized in yeasts and mammals. The number of C-mannosyltransferases remains unknown. Following 
mannosyl transfer, Dol-P is released and returned to the cytosolic monolayer by Flippase 4.
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arising from inadequate Dol-P synthesis (DHDDS-CDG, 
SRD5A3-CDG, and DK-CDG), and it is possible that defi-
ciencies in Dol-P recycling could be partially alleviated by the 
upregulation of Dol-P synthesis de novo.25 It is interesting to 
note that a CDG attributed to the recycling DolPP1 has not 
yet been reported.
Despite continued keen interest in the putative flippases 
of the protein glycosylation pathways of the ER, they 
remain undescribed due, primarily, to technical difficulties 
inherent in assaying their biochemical activity. Current 
analytical approaches are based on localizing a specific DLO 
intermediate to one leaflet of the bilayer by using chemical 
modification with a membrane-impermeant reagent,5,26,27 or 
lectin capture,5,28 or transport of water-soluble analogs con-
taining short isoprenyl chains.29–32 The existing evidence 
suggests that the DLO flippases are energy independent and 
bidirectional and catalyze an extremely rapid equilibration of 
DLO intermediates between the monolayers, with half-times 
in the range of a minute or less. These properties, along with the 
inherent fragility of transbilayer asymmetry, pose formidable 
experimental challenges to using classical biochemical 
methodologies. This article reviews the information that is 
currently available concerning the flippase activities of the 
protein glycosylation pathways of the eukaryotic ER. Results 
and observations from some previously unpublished studies 
are included. All studies were conducted in accordance with 
federal guidelines and approved by the Institutional Animal 
Care and Use Committee of the University of Kentucky.
Man-P-Dol Flippase
As noted earlier, Man-P-Dol is synthesized on the cyto-
solic surface of the ER from GDP-Man and dolichol phos-
phate by Dpm1 in Saccharomyces cerevisiae and a complex of 
three polypeptide subunits (Dpm1, Dpm2, and Dpm3) in 
other eukaryotes.15,33 Following synthesis, Man-P-Dol dif-
fuses transversely through the ER membrane to the lumenal 
monolayer, where it functions as a mannosyl donor for the 
C-mannosylation of tryptophan residues in thrombospon-
din repeats of cell surface receptors, the O-mannosylation 
of serine and threonine units of α-dystroglycan, the addi-
tion of four Man residues of the DLO intermediate of the 
N-glycosylation pathway, and three (or more) Man units of 
GPI anchor intermediates,15,34 as illustrated in Figure 2.
The molecular description of the proteins involved in 
the transmembrane diffusion of Man-P-Dol has been a sub-
ject of interest for a number of years.35,36 However, due to the 
absence of a convenient biochemical assay for Man-P-Dol 
flippase activity, progress has been slow. Genetic approaches 
have also failed to identify likely flippase candidate pro-
teins, including two recent screens in Hap1 cells (haploid 
mammalian cell lines) for defects in GPI assembly. Both of 
these screens identified all of the proteins known to partici-
pate in GPI formation but failed to identify any proteins that 
could plausibly be involved in the transmembrane flipping of 
either Man-P-Dol or glucosamine-PI.37,38 There are a num-
ber of potential explanations for this observation, including 
the possibility, as is true in yeast, that an essential protein is 
synthesized by a flippase requiring pathway, in this case an 
essential GPI-anchored protein,39,40 or that multiple genomic 
copies of flippase genes are present, making it difficult to elim-
inate all of the active transcripts. It is possible that flippases 
from other pathways possess overlapping substrate specificity, 
allowing complementation of the defect by other flippases, or 
the flippase activity may reside in a multitasking protein with 
another essential function as a second moonlighting activity.41 
This final possibility is supported by the recent discovery that 
Rhodopsin, in addition to its role as a visual pigment and G 
protein-coupled receptor, also functions as an active phospho-
lipid flippase in photoreceptor disc membranes.27,42
Two strategies for the in vitro measurement of Man-P-Dol 
flippase activity have been developed. One approach, relies on 
the use of a water-soluble version of Man-P-Dol containing 
citronellyl phosphate (Cit-P), a short-chain analog of Dol-P 
with a 10 carbon isoprenyl chain and a saturated α-isoprene. 
This assay relies on the assumption that recognition of the 
polar head group and its movement across the bilayer are the 
most critical aspects of the flipping process and measures 
Man-P-Dol flipping as a simple transport process into sealed 
rat liver ER vesicles.29,32,43 This is a variation of the approach 
used by Bishop and Bell to assay flip-flopping of phosphatidyl-
choline in ER vesicles.44
The selection of Man-P-Cit as an appropriate analog for 
Man-P-Dol is strongly supported by the observation that Man- 
P-Cit is a suitable substrate for all the Man-P-Dol-mediated 
mannosyltransferases in the DLO pathway45 and in GPI 
assembly,46 in O-mannosylation,47 and in C-mannosylation 
(J. S. Rush, C. J. Waechter, and J. Hofsteenge, 2008, unpub-
lished observation). Furthermore, Man-P-Cit was able to 
allosterically stimulate GlcNAc-P-P-Dol synthesis,48 similar to 
native Man-P-Dol, and was able to cross the ER membrane and 
function as a mannosyl donor in streptolysin-O-permeabilized 
Lec35 cells under conditions in which the Man-P-Dol utili-
zation defect was preserved.34 Lec35 cells exhibit a defect in 
Man-P-Dol and Glc-P-Dol utilization that, apparently, does 
not involve dolichol-intermediate flipping.34
Man-P-Cit is transported into the lumen of intact rat liver 
ER vesicles by a process that is time dependent, reversible, sat-
urable, protease sensitive, stereoselective, enriched in the ER, 
sensitive to incubation with diethylpyrocarbonate (DEPC), 
and energy independent.29 The activity was not observed in 
intact erythrocytes or synthetic liposomes29 but was observed 
in proteoliposomes reconstituted from octyl glucoside and Tri-
ton X-100 soluble detergent extracts of rat liver ER membrane 
proteins.43 Furthermore, the soluble detergent extracts could 
be fractionated by ion exchange and partially purified.43 It is 
observed that when Man-P-Cit uptake in intact rat liver ER 
vesicles is measured over a range of temperatures, an Arrhe-
nius plot of the rate of transport reveals an inflection point 
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at ~16°C, correlating exactly with a corresponding inflec-
tion point in the rate of increase in the incorporation of [3H]
mannose units into [3H]Man6–9-DLO from GDP-[3H]Man 
(which requires the participation of [3H]Man-P-Dol as an 
intermediate), performed in a parallel incubation (J. S. Rush 
and C. J. Waechter, 2007, unpublished observation). In this 
experiment, the increase in the initial rate of incorporation 
of [3H]mannose into [3H]Man-P-Dol is linear with respect 
to temperature, as would be anticipated for a process occur-
ring on only one side of the membrane bilayer. This obser-
vation is consistent with Man-P-Cit uptake and Man-P-Dol 
flipping occurring by a transport process, which is affected 
similarly by membrane fluidity and supports the conclusion 
that Man-P-Cit transport accurately reflects flippase activity.
An alternative approach utilized native [3H]Man-P-Dol 
symmetrically reconstituted into sealed synthetic proteolipo-
somes and a membrane-impermeant oxidant (carboxy-2,2,6,6-
tetramethylpiperidine 1-oxyl NO+) to selectively modify the 
[3H]Man-P-Dol molecules located in the outer monolayer of 
the synthetic vesicles.5,26 In this method, 50% of the [3H]Man-
P-Dol in phospholipid vesicles lacking an active flippase will be 
oxidized. The remaining 50% is sequestered within the inner 
monolayer of the vesicle and is protected from reaction with the 
oxidant. However, in vesicles equipped with an active flippase, 
the [3H]Man-P-Dol facing the lumen of the proteoliposome is 
able to equilibrate into the outer monolayer and be oxidized. 
The result is that a larger fraction of the [3H]Man-P-Dol will be 
subject to oxidation. This study demonstrated rapid transbilayer 
movement of Man-P-Dol that is protein dependent, energy 
independent, DEPC sensitive, and highly specific for both the 
anomeric configuration of Man and a reduced α-isoprene unit.26
Further studies showed that Man-P-Dol flippase activity 
could be resolved from flippase activities that mediate the 
transmembrane movements of M5-DLO (see Man5GlcNAc2-
P-P-Dol flippase section) and glycerophospholipid flippase 
by concanavalin A (ConA) affinity and ion-exchange 
chromatography.26 Limiting dilution of these detergent-
soluble extracts into phospholipid vesicles leads to the con-
clusion that the Man-P-Dol flippase constitutes ~1% of the 
proteins in the detergent extract.26
Flippase assays based on water-soluble analog transport 
have the advantages of simplicity and rapidity and allow near-
initial rate estimations in the absence of detergents.29,32 The 
alternative method employing full-length Man-P-Dol avoids 
potential concerns arising from the use of structural ana-
logs,5,26 but relies on the reconstitution of detergent-solubilized 
membrane preparations, and is potentially limited by the time 
constraint imposed by reaction with the mannolipid, which 
may significantly exceed the extremely rapid time course of 
transmembrane diffusion, even at 0°C (t , 7 minutes).5,26 In 
this regard, it is important to note that the properties of the 
Man-P-Cit transport activity in rat liver ER vesicles were iden-
tical to the activity reconstituted from detergent extracts, so the 
probability that some essential intrinsic property of the flippase 
system is affected by detergent solubilization and reconstitu-
tion is very low. Although neither method has yet yielded a 
full molecular description of the Man-P-Dol flippase proteins, 
some preliminary properties have been identified and it is 
reassuring that the apparent properties of the flippase protein 
determined by the two methods are very similar. The comple-
mentary analytical methods identify an activity that is energy 
independent, bidirectional, stereoselective, sensitive to proteol-
ysis and protein alkylation by DEPC and NEM, and amenable 
to fractionation by a variety of chromatographic approaches.
Glc-P-Dol Flippase
Glc-P-Dol is synthesized by Glc-P-Dol synthase (ALG5) 
using UDP-Glc as glucosyl donor and Dol-P as the lipid 
acceptor on the cytosolic surface of the ER but functions as 
a glucosyl donor in the synthesis of G3-DLO on the lume-
nal monolayer.49,50 The topological reorientation of Glc-P-Dol 
has been studied in sealed, ER-enriched microsomal vesicles 
from pig brain and rat liver by following the transport of a 
water-soluble Glc-P-Dol analog, Glc-P-citronellol (Glc-P-
Cit).30 Similar to the properties of the Man-P-Dol flippase 
reported earlier, Glc-P-Cit uptake in rat liver ER vesicles is 
time dependent, saturable, bidirectional, trypsin sensitive, 
and completely dependent on an intact permeability barrier. 
Furthermore, Glc-P-Cit is not taken up by synthetic lipo-
somes or erythrocytes and Glc-P-Cit transport activity frac-
tionates with heavy microsomes (ER-enriched) in brain.30 
The molecular description of the Glc-P-Dol flippase protein 
remains a high priority, as severely affected human patients 
with CDG attributable to defects in the enzymes that catalyze 
attachment of Glc units to the DLO intermediate (ALG6 and 
ALG8) have been identified and genetic defects in Glc-P-Dol 
flipping would be expected to have similar pathologies.51
Man5GlcNAc2-P-P-Dol Flippase
M5-DLO is synthesized from Dol-P, UDP-GlcNAc, and 
GDP-Man on the cytosolic surface of the ER (Fig. 1) by two 
multienzyme complexes, consisting of DPAGT1, ALG13, 
and ALG14 that form GlcNAc2-P-P-Dol10 and ALG1, 
ALG2, and ALG11 that add one b-mannosyl and four 
α-mannosyl units to form M5-DLO.11 The transmembrane 
diffusion of the M5-DLO intermediate is particularly inter-
esting due to the presumed difficulty involved in the passage 
of this large, extremely hydrophilic head group through the 
hydrophobic core of the ER membrane.28,52,53 The identifi-
cation of the yeast RFT1 protein as a candidate M5-DLO 
flippase, primarily based on genetic evidence by Hele-
nius et al, was an exciting development.54 RFT1-depleted 
yeast cells accumulate large quantities of M5-DLO and are 
severely defective in protein N-glycosylation despite possess-
ing normal levels of Man-P-Dol synthase and no apparent 
defect in the Man-P-Dol: M5-DLO mannosyltransferases 
(ALG3, ALG9, and ALG12).54 However, direct biochemi-
cal assay of M5-DLO flippase activity by two independent 
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methods indicates that although RFT1 is clearly required for 
proper assembly of the full-length DLO intermediate, it is 
dispensable for M5-DLO flipping in vitro.28,55–57
M5-DLO flipping has been measured directly in 
reconstituted proteoliposomes, employing a ConA binding 
assay.26,28,55,56 In this assay, proteoliposomes are reconstituted 
from Triton X-100 soluble cellular extracts and exogenous 
phospholipids with traces of [3H]M5-DLO equally distrib-
uted between the two monolayers. When incubated with sol-
uble ConA, the radiolabeled DLO in the outer leaflet of the 
proteoliposome is bound by ConA and cannot be extracted 
into organic solvent, whereas since ConA cannot spontane-
ously cross the membrane bilayer, the DLO in the inner leaflet 
is sequestered from the ConA and, as a result, is fully extract-
able. Ideally, in proteoliposomes lacking an active flippase, 
only 50% of the [3H]M5-DLO is extractable. In proteolipo-
somes containing an active flippase, unbound M5-DLO is able 
to equilibrate with the outer monolayer and become bound by 
ConA. Consequently, a smaller fraction of the intermediate is 
extractable in liposomes containing a flippase activity. Using 
this assay, M5-DLO flipping was shown to be extremely 
rapid (a rate constant of . 2 × 10-3 s-1), protein dependent, 
energy independent, bidirectional, and protease sensitive. 
Significantly, the M5-DLO flippase activity could be resolved 
from an unrelated phospholipid flippase activity by several 
chromatographic methods.56 Furthermore, the M5-DLO 
flippase activity preferred the natural M5-DLO isomer over a 
catabolic M5-DLO intermediate, with an alternative branch-
ing pattern, and a biosynthetic M7-DLO intermediate dem-
onstrating a high degree of substrate specificity.56 A further 
report showed that M5-DLO flipping was inhibited by the 
inclusion of GlcNAc2-P-P-Cit, a water-soluble M5-DLO 
analog, and that whereas M5-DLO was rapidly flipped with 
a time constant t , 2 minutes, the triantennary intermediate 
M3-DLO flipped much more slowly with t , 200 minutes. 
DLOs larger than M5-DLO also flipped slowly with t values 
ranging from 10 to . 200 minutes.28 Importantly, this activity 
was present in Triton X-100 soluble extracts derived from cells 
in which RFT1 had been depleted and was not immunopre-
cipitated with specific antibody to epitope-tagged RFT1.28,55 
In addition, M5-DLO flippase activity could be resolved from 
the epitope-tagged RFT1 protein by velocity sedimentation, 
ion-exchange, and blue dye resin chromatography.28,55
In another set of studies, sealed ER vesicles from 
RFT1-depleted yeast cells were fully capable of elongating 
[3H]GlcNAc2-P-P-Dol, synthesized in situ, to form [3H]
M9-DLO in vitro when incubated with nonradioactive GDP-
Man.57 As this elongation reaction cannot occur without 
translocation of the DLO intermediate to the lumenal com-
partment, this is strong evidence that the RFT1-depleted 
microsomes are still capable of flipping M5-DLO. GlcNAc2-
P-P-Dol has been shown to be flipped, presumably by the 
M5-DLO flippase in microsomes from a variety of tissues and 
yeasts.58–63 To measure M5-DLO flipping directly in sealed 
yeast ER vesicles, the transport of [3H]GlcNAc2-P-P-Dol15, 
a water-soluble analog of GlcNAc2-P-P-Dol with a 15-carbon 
α-reduced isoprenol chain, was measured. RFT1-depleted, 
ER-enriched yeast microsomes transported water-soluble 
[3H]GlcNAc2-P-P-Dol15 into the lumen of the sealed vesicles 
at an even faster rate than intact vesicles from undepeleted 
cells.57 Furthermore, when the sealed RFT1-depleted micro-
somal vesicles were incubated with a membrane-permeant 
N-glycosylation acceptor peptide and [3H]GlcNAc2-P-P-Dol15, 
the peptide was glycosylated with [3H]GlcNAc2, presumably 
by the lumenal oligosaccharyltransferase (OST), demonstrat-
ing that the water-soluble analog has access to the lumenal 
compartment.57 Finally, in an indirect assay for the recycling of 
Dol-P,14 it is observed that when sealed RFT1-depleted yeast 
microsomal vesicles are incubated with a membrane-permeant 
N-glycosylation acceptor peptide, a very large amount of newly 
formed Dol-P is generated (J. S. Rush and C. J. Waechter, 
2008, unpublished observation). This assay was previously used 
to successfully establish the biochemical mechanism, by which 
Dol-P derived from Dol-P-P, generated by the N-glycosylation 
reaction, is returned to the cytosolic monolayer for further 
rounds of DLO synthesis14 and is strong evidence that a large 
portion of the accumulated M5-DLO can enter the lumen of 
the ER in vesicles prepared from RFT1-depleted cells and 
become accessible to OST.
This biochemical evidence strongly suggests that RFT1 
is not an essential subunit of the M5-DLO flippase in ER 
vesicles isolated from disrupted cells. Recently, this conclu-
sion has been further supported by the observation that 
mutant Trypanosoma brucei cells lacking RFT1 are viable and 
N-glycosylate protein normally despite accumulating a large 
amount of M5-DLO.64 The exact role of RFT1 in the syn-
thesis of full-length DLOs in vivo and the identity of the 
M5-DLO flippase remain to be elucidated, but RFT1’s role 
may be similar to that of the CHO Lec35 protein (MPDU1), 
which appears to be required for the utilization of both Man-
P-Dol and Glc-P-Dol, in vivo, but is dispensable in vitro.34
Dol-P Flippase
Dol-P is formed on the lumenal surface of the ER membrane 
from several biosynthetic processes, including (1) cleavage 
of Dol-P-P generated during the OST reaction of protein 
N-glycosylation, (2) the three glucosyltransferase reactions 
utilizing Glc-P-Dol, and (3) by all of the Man-P-Dol-mediated 
mannosyltransferase reactions (the four DLO mannosyltrans-
ferases, the three GPI anchor mannosyltransferases and C- 
and O-mannosylation; see Fig. 2) utilizing Man-P-Dol as 
mannosyl donor.6,14 This lumenally oriented Dol-P must be 
returned to the cytosolic surface of the ER in order to par-
ticipate in further rounds of glycan synthesis. The recycling of 
Dol-P substantially contributes to the maintenance of biologi-
cally relevant rates of protein N-glycosylation, as a significant 
reduction of glycosylation is observed in the yeast DolPP1 
mutant, CWH8, even though this mutation presumably 
Protein glycosylation in the endoplasmic reticulum 
51Lipid insights 2015:8(s1)
affects only the recycling of Dol-P from DLO and not the 
substantial number of Dol-P molecules arising from the other 
glycosyltransferase reactions.14 Despite the clear significance 
of the recycling of the lipid anchor, the molecular and bio-
chemical details of this process remain virtually unknown. It 
will be worth exploring the possibility that CWH8 (DolPP1) 
plays a role in the translocation of Dol-P back to the cytosolic 
surface of the ER.
Presumably, Dol-P is returned to the cytoplasmic 
monolayer by a flippase-mediated process, as the amphipa-
thic lipid anchor is unable to spontaneously cross the hydro-
phobic interior of the membrane bilayer. However, the 
identity of this flippase has not been established. Indeed, it 
is not known if multiple, unique flippases are associated with 
the various glycosyltransferases and the DolPP1 involved in 
the production of lumenal Dol-P mentioned earlier. A mem-
brane-associated activity that transports Cit-32P (a water-
soluble analog of Dol-P) into the lumen of sealed vesicles has 
been detected (J. S. Rush and C. J. Waechter, 2006, unpub-
lished observation), as shown in Figure 3. When sealed rat 
liver ER vesicles are incubated with Cit-32P, the analog is 
rapidly transported into the lumen of the vesicle with an 
apparent half-time of uptake of ~23 seconds (Fig. 3, panel 
A). When the ER vesicles are first loaded with Cit-32P by 
preincubation and then diluted into isotonic buffer at room 
temperature, the internalized Cit-32P effluxes from the vesi-
cles with a half-time of exit of ~30 seconds, showing that the 
uptake process is fully reversible (Fig. 3, panel A). Cit-32P 
does not spontaneously leak out of protein-free phospholipid 
vesicles, as shown in Figure 3, panel B (half-time of exit ~94 
hours). Preliminary studies indicate that as with the other 
ER-associated flippase activities, this activity is membrane 
protein dependent, time dependent, protease sensitive, and 
energy independent (J. S. Rush and C. J. Waechter, 2006, 
unpublished observation). The identity of the protein medi-
ating the return of Dol-P to the cytosolic monolayer has not 
yet been determined, but recycling by an antiport mecha-
nism via one of the other flippase activities seems unlikely, 
as Cit-P does not have any appreciable effect on the uptake 
or efflux of any of the other water-soluble analogs employed 
in flippase assays.
Concluding Comments
The transbilayer diffusion of Man-P-Dol in the ER mem-
brane was first investigated by Haselbeck and Tanner using 
an elegant enzyme-coupled assay over 40 years ago.35,36 
Despite continued interest in the mechanism of Man-P-Dol 
flipping in the ER, the proteins that participate in this essen-
tial step involved in C- and O-mannosylation, DLO synthe-
sis, and GPI anchor formation in the ER remain unidentified. 
The fragility of the topological asymmetry of the lipid bilayer 
and the apparent physical properties of the putative flip-
pases have presented substantial experimental difficulties 
to the direct measurement of flippase activity in vitro. The 
biochemical assays reviewed here are important advances 
and have led to the identification of a number of physical 
properties of the prospective flippases. In common with the 
glycerophospholipid flippases present in biogenic membranes, 
Figure 3. transport of 32P-Cit into the lumen of intact rat liver ER vesicles. Panel A, open circle (○), 32P-Cit was incubated with sealed rat liver ER vesicles 
at 22°C for the indicated periods of time. Following incubation, the transport reactions were diluted with 0.5 mL ice-cold buffer (10 mM Tris-CL, pH 7.4, 
0.25 M sucrose) and filtered through a Millipore 0.45 µm HA filter. The filters were washed with an additional 10 mL ice-cold buffer and assayed for 
radioactivity, as described earlier.29 Panel A, closed circle (), sealed rat liver ER vesicles were pre-incubated with 32p-Cit for 10 minutes and diluted 
with 0.5 mL, 10 mM Tris-Cl, pH 7.4, and 0.25 M sucrose all at 22°C. At the indicated times, the diluted reactions were filtered through a 0.45 µm hA 
filter, washed with an additional 10 mL ice-cold buffer, and assayed for radioactivity. Panel B, large unilamellar synthetic phospholipid vesicles were 
reconstituted from octyl glucoside soluble phospholipids in the presence of 32P-Cit, as described elsewhere.43,67 The vesicles containing 32p-Cit entrapped 
in the lumen were incubated with 10 mM Tris-Cl, pH 7.4, and 0.25 M sucrose at 22°C for the indicated periods of time and chromatographed on a 30 mL 
column of Sephadex G-50 equilibrated in 10 mM Tris-Cl, pH 7.4, and 0.25 M sucrose. Fractions of 1 mL were collected and monitored for radioactivity by 
scintillation spectrometry. The percentage of the radioactivity eluting in the void volume of the column is plotted versus time of incubation.
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the ER dolichol-intermediate flippases are bidirectional and 
energy independent and catalyze an extremely rapid reequili-
bration of the intermediates between the two monolayers. 
Hypothetical models for flippase action have been proposed 
by Kol et al,65 Sanyal and Menon,5,26 and Ernst and Menon.66 
It is possible that the translocation events are energy inde-
pendent for lipid intermediates because the flipping is driven 
by mass action, as the intermediates are rapidly utilized at 
the lumenal sites. It  is also reassuring that although the 
experimental approaches employed in these assays differ sig-
nificantly, the individual studies identify very similar physi-
cal properties, which are also consistent with observations 
from coupled in vitro enzymatic systems. The development 
of reliable methods for the solubilization, fractionation, and 
functional reconstitution of the flippase activities coupled 
to proteomic approaches paves the way for the purification, 
identification, and characterization of these final undescribed 
steps in protein glycosylation in the ER.
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